Biocon Biologics and Viatris Receive European Commission Approval for Kixelle, Biosimilar Insulin Aspart

  • Thu, 11-Feb-2021
  • Posted by: Biocon Biologics
No Comments
Author: Biocon Biologics
Report adverse event/ side effects and/or product complaints for Biocon Biologics products.

* Safe Harbour | Privacy Policy | Terms of Use © 2023, Biocon Biologics Limited (a Subsidiary of Biocon Limited). All Rights Reserved
Share